
You can purchase shares of iShares U.S. Pharmaceutical ETF (ARCA:IHE) through any online brokerage.
There are no as such competitors for iShares U.S. Pharmaceutical ETF.
There is no analysis for iShares U.S. Pharmaceutical ETF to provide a consensus price target.
The stock price for iShares U.S. Pharmaceutical ETF (ARCA: IHE) is $101.075 last updated October 16, 2026 at 12:43 PM EDT.
There are no upcoming dividends for iShares U.S. Pharmaceutical ETF.
iShares U.S. Pharmaceutical ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares U.S. Pharmaceutical ETF.
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | May 1, 2006 |
| Managers | Paul Whitehead Jennifer Hsui Matt Waldron |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
Benzinga Rankings give you vital metrics on any stock – anytime.